In yesterday’s Wall Street session, Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) shares traded at $20.76, down -3.58% from the previous session.
ARWR stock price is now 0.01% away from the 50-day moving average and -9.00% away from the 200-day moving average. The market capitalization of the company currently stands at $2.58B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $31, Goldman recently initiated with Neutral rating for Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR). On December 04, 2023, BofA Securities recently initiated its ‘Buy’ rating on the stock quoting a target price of $29, while ‘Citigroup’ rates the stock as ‘Neutral’
In other news, OLUKOTUN ADEOYE Y, Director bought 959 shares of the company’s stock on Jan 23 ’25. The stock was bought for $20,108 at an average price of $20.97. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 06 ’25, Chief Discovery/Trans Medicine Hamilton James C sold 32,729 shares of the business’s stock. A total of $648,824 was realized by selling the stock at an average price of $19.82. This leaves the insider owning 272,122 shares of the company worth $5.65 million. A total of 6.90% of the company’s stock is owned by insiders.
During the past 12 months, Arrowhead Pharmaceuticals Inc has had a low of $17.05 and a high of $36.72. As of last week, the company has a debt-to-equity ratio of 4.59, a current ratio of 6.74, and a quick ratio of 6.74. The fifty day moving average price for ARWR is $20.7582 and a two-hundred day moving average price translates $22.813826 for the stock.
The latest earnings results from Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) was released for 2024-06-30. The net profit margin was -16882.37% and return on equity was -262.48% for ARWR.
